⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Hepatic Growth Hormone Receptor Signaling in Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-07 — Plasma proteomic signatures of biological aging and metabolic dysfunction-associated steatotic liver disease risk: a prospective cohort study.: cross-connection with inflammaging: A biological-aging → inflammatory-protein → MASLD mediation axis in humans complements the preclinical hepatocyte-GHR-ablation route to steatosis and aging phenotypes, converging on liver as a tissue where systemic aging signals are read out as metabolic-inflammatory disease. (novelty: 3)
- 2026-10-01 — Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction.: Hepatocyte-specific GHR knockout mouse study: liver-autonomous loss of GH signaling drove systemic aging phenotypes and hepatic steatosis via PPARγ-driven PDK4/CD36 upregulation and mitochondrial dysfunction, with pharmacological PDK4 inhibition rescuing the pathology — concrete downstream effector (PDK4) identified for the hepatic GHR axis. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction.
01-oct-2026
novelty 3
per-area 3
strengthens